Health Disparities in Achieving Sustained Virologic Response Among Patients With Chronic Hepatitis C: A Retrospective Single-Center Study. [PDF]
Leach E +5 more
europepmc +1 more source
Economic evaluations of Glecaprevir/Pibrentasvir and Grazoprevir/Elbasvir for the treatment of hepatitis C: a systematic review. [PDF]
Jafari M +7 more
europepmc +1 more source
Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study. [PDF]
Abdel-Salam Elgohary M +10 more
europepmc +1 more source
Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation. [PDF]
Brzdęk M +10 more
europepmc +1 more source
Evaluation of portal venous flow velocity before and after direct acting antiviral therapy in chronic hepatitis C: A cohort study. [PDF]
Çolakoğlu Er H, Er RE, Yildirim AE.
europepmc +1 more source
To treat or not to treat young children with hepatitis C?--real-life experience. [PDF]
Pokorska-Śpiewak M +4 more
europepmc +1 more source
State and Federal Policy Solutions to Rising Prescription Drug Prices in the U.S. [PDF]
Padula, William V.
core +1 more source
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up. [PDF]
Benjaram S +7 more
europepmc +1 more source
KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma. [PDF]
Xu Q, Chen W, Cao S, Li X, Wu X, Ma X.
europepmc +1 more source

